Advances in alzheimer therapy

Understanding Pharmacological approaches to the disease

Ana Martínez, Debomoy Lahiri, Ezio Giacobini, Nigel H. Greig

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Although significant accomplishments have been made in research to understand, diagnose and treat Alzheimer's disease (AD) and its prequel, mild cognitive impairment, over the last two decades, a huge amount more remains to be achieved to impact this incurable, terminal disease that afflicts an estimated 26.6 million people worldwide. Increasing evidence indicates that early diagnosis will be fundamental to maximizing treatment benefits. Moreover, mechanistically-based, hypothesis-driven treatment strategies are now emerging to hopefully spearhead future therapy. The cross-fertilization of ideas from multiple disciplines will prove key to optimize strategies and translate them to meaningful clinical utility, and forms the basis of the current issue focused on "Advances in Alzheimer therapy".

Original languageEnglish
Pages (from-to)83-85
Number of pages3
JournalCurrent Alzheimer Research
Volume6
Issue number2
DOIs
StatePublished - Apr 2009

Fingerprint

Pharmacology
Fertilization
Early Diagnosis
Alzheimer Disease
Therapeutics
Research
Cognitive Dysfunction

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Advances in alzheimer therapy : Understanding Pharmacological approaches to the disease. / Martínez, Ana; Lahiri, Debomoy; Giacobini, Ezio; Greig, Nigel H.

In: Current Alzheimer Research, Vol. 6, No. 2, 04.2009, p. 83-85.

Research output: Contribution to journalArticle

Martínez, Ana ; Lahiri, Debomoy ; Giacobini, Ezio ; Greig, Nigel H. / Advances in alzheimer therapy : Understanding Pharmacological approaches to the disease. In: Current Alzheimer Research. 2009 ; Vol. 6, No. 2. pp. 83-85.
@article{28fc11d7f6b54a06896f7146c7199913,
title = "Advances in alzheimer therapy: Understanding Pharmacological approaches to the disease",
abstract = "Although significant accomplishments have been made in research to understand, diagnose and treat Alzheimer's disease (AD) and its prequel, mild cognitive impairment, over the last two decades, a huge amount more remains to be achieved to impact this incurable, terminal disease that afflicts an estimated 26.6 million people worldwide. Increasing evidence indicates that early diagnosis will be fundamental to maximizing treatment benefits. Moreover, mechanistically-based, hypothesis-driven treatment strategies are now emerging to hopefully spearhead future therapy. The cross-fertilization of ideas from multiple disciplines will prove key to optimize strategies and translate them to meaningful clinical utility, and forms the basis of the current issue focused on {"}Advances in Alzheimer therapy{"}.",
author = "Ana Mart{\'i}nez and Debomoy Lahiri and Ezio Giacobini and Greig, {Nigel H.}",
year = "2009",
month = "4",
doi = "10.2174/156720509787602924",
language = "English",
volume = "6",
pages = "83--85",
journal = "Current Alzheimer Research",
issn = "1567-2050",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Advances in alzheimer therapy

T2 - Understanding Pharmacological approaches to the disease

AU - Martínez, Ana

AU - Lahiri, Debomoy

AU - Giacobini, Ezio

AU - Greig, Nigel H.

PY - 2009/4

Y1 - 2009/4

N2 - Although significant accomplishments have been made in research to understand, diagnose and treat Alzheimer's disease (AD) and its prequel, mild cognitive impairment, over the last two decades, a huge amount more remains to be achieved to impact this incurable, terminal disease that afflicts an estimated 26.6 million people worldwide. Increasing evidence indicates that early diagnosis will be fundamental to maximizing treatment benefits. Moreover, mechanistically-based, hypothesis-driven treatment strategies are now emerging to hopefully spearhead future therapy. The cross-fertilization of ideas from multiple disciplines will prove key to optimize strategies and translate them to meaningful clinical utility, and forms the basis of the current issue focused on "Advances in Alzheimer therapy".

AB - Although significant accomplishments have been made in research to understand, diagnose and treat Alzheimer's disease (AD) and its prequel, mild cognitive impairment, over the last two decades, a huge amount more remains to be achieved to impact this incurable, terminal disease that afflicts an estimated 26.6 million people worldwide. Increasing evidence indicates that early diagnosis will be fundamental to maximizing treatment benefits. Moreover, mechanistically-based, hypothesis-driven treatment strategies are now emerging to hopefully spearhead future therapy. The cross-fertilization of ideas from multiple disciplines will prove key to optimize strategies and translate them to meaningful clinical utility, and forms the basis of the current issue focused on "Advances in Alzheimer therapy".

UR - http://www.scopus.com/inward/record.url?scp=64549128224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64549128224&partnerID=8YFLogxK

U2 - 10.2174/156720509787602924

DO - 10.2174/156720509787602924

M3 - Article

VL - 6

SP - 83

EP - 85

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1567-2050

IS - 2

ER -